One hundred ten primary hepatic neoplasms, excluding hematopoietic and vascular tumors, were diagnosed in 12,245 canine necropsies. Included were 55 hepatocellular carcinomas, 24 bile duct carcinomas, 2 combined hepatocellular and cholangiocarcinomas, 15 carcinoids and 14 sarcomas. A majority of the dogs with hepatocellular carcinoma (80%), bile duct carcinoma (65%) and sarcoma (61%) were 10 years old or older; 71% of the dogs with carcinoid were under 10 years old. Hepatocellular carcinoma and sarcoma occurred more often in males, bile duct carcinoma in females, and no sex predisposition was found in dogs with carcinoid. All dogs had hematologic and biochemical abnormalities relating to liver function. The aspartate amino transferase/alanine amino transferase ratio was less than one in cases of hepatocellular carcinoma and bile duct carcinoma, and more than one in cases of carcinoid and sarcoma. A massive lesion in one of the liver lobes was the most common gross morphologic feature in cases of hepatocellular carcinoma and bile duct carcinoma, with the left lateral lobe affected most often. In cases of carcinoid, most of the lesions were diffuse. The most common sites of metastases were lymph nodes and lungs for hepatocellular carcinoma and bile duct carcinoma, lymph nodes and peritoneum for carcinoid, and spleen for sarcoma.
Neoplasms of the liver and biliary tracts are uncommon in domestic animals [3, 6, 15, 16, 22, 23, 26, 31, 361 . Frequency in the dog vanes from 0.6% to 1.3% of all neoplasms [6, 9, 15, 16, 18, 31, 33] . Only a few studies deal with the clinicopathologic features of a large number of canine primary hepatic neoplasms [4, 12, 14, 15, 28, 31, 331 .
Materials and Methods
Case records and histologic specimens from dogs with hepatic neoplasms seen between 1962 and 1977 at The Animal Medical Center were reviewed. AU cases with enough slides to confirm the diagnosis were included in the study. Details of the 110 dogs' clinical and gross pathologic fmdings were collected from the medical and necropsy records. Because neoplasms arising from the hematopoietic and vascular systems usually involve several organs, they were excluded from this study. Hepatocellular adenoma, intrahepatic bile duct adenoma and bile duct cyst adenoma also were excluded because of their high frequency and because of the difficulty in distinguishing between nodular hyperplasia and hepatocellular adenoma.
The hepatic neoplasms were grouped under hepatocellular carcinoma, bile duct carcinoma, carcinoid, and sarcoma, based on the histologic criteria described for human and animal tumors [8, 11, 22, 27, 31, 321 . The determination of liver as primary site was based on the clinical signs and biochemical fmdings relating to the liver, gross and histologic findings, and elimination of the possibility of other sites as primary. In cases of sarcoma, in which both the spleen and liver usually were involved, if the liver had the largest single lesion, it was considered the primary site; smaller, multiple well-defined nodules in the liver were considered metastases, and these cases were not included in the study.
In addition to these factors establishing the liver as the primary site, one or more of the following features were taken into consideration in making a diagnosis of hepatocellular carcinoma: the histologic patterns of the neoplasm; intrahepatic and extrahepatic metastases; cellular pleomorphism and anaplasia; mitotic activity; absence of histologic boundaries; and absence of the usual hepatic lobular pattern.
The bile duct carcinomas were diagnosed on the basis of their tubular structure and cystic structure with solid or papillary arrangement of cells. The combined hepatocellular and cholangiocarcinomas were characterized by the presence of hepatocellular carcinoma and bile duct carcinoma components in the same neoplasm.
In cases of carcinoid, other possible sites of primary neoplasm were ruled out grossly and histologically. These neoplasms did not have the histologic pattern of hepatocellular carcinoma or bile duct carcinoma; they were, however, consistent with the typical histologic patterns of carcinoids described in man [8, 32, 351 . The histologic criteria for the diagnosis of carcinoid were: peritheliomatous arrangement typical of endocrine neoplasms; small to medium-sized cells arranged in solid nests, cords or ribbon-like structures, in groups of rosettes or in any mixture of these three; various degrees of desmoplastic stromal reaction with hyalinization and focal mineralization; and presence of argyrophilia. This group of neoplasms stood out, not only as a histologic entity, but also as having distinct clinical, biochemical and gross morphologic features.
The sarcomas were diagnosed on the basis of their histologic and special staining characteristics.
Tissues for histologic examination were fwed in 10% buffered formalin, processed routinely, and 4to 6-pm sections were stained with hematoxylin and eosin (HE). Mucicarmine, modified
Grimelius stain, periodic acid-Schiff (PAS) and Masson's trichrome stains also were used.
Results

Frequency
During the period of study, 110 primary hepatic neoplasms were diagnosed: 55 hepatocellular carcinomas, 24 bile duct carcinomas, 2 carcinomas with features of both hepatocellular carcinoma and bile duct carcinoma that were included with the hepatocellular carcinoma for further evaluation, 15 carcinoids and 14 sarcomas (table I). One bile duct carcinoma arose from the main bile duct and another from the gallbladder. The hepatocellular carcinomas composed 59.4%, the bile duct carcinomas 25%, and the carcinoids 15% of the primary epithelial tumors of the liver.
The sarcoma group included 10 leiomyosarcomas, 3 fibrosarcomas and 1 extraskeletal osteogenic sarcoma.
Age, breed, and sex
For age and sex distributions of the dogs in this study see table 11. The average age of dogs with hepatocellular carcinoma was 11 years; 80% were 10 years old or older. Most bile duct carcinomas (65%) and sarcomas (61%) occurred in dogs older than 10 years; average ages were 10 and 11 years, respectively. In contrast, 71% of the hepatic carcinoids occurred in dogs under 10 years old; the average age was 8 years.
Most dogs with hepatocellular carcinoma were male, and with bile duct carcinoma, female. Sarcoma occurred in male dogs twice as often as in female dogs, but carcinoid occurred with the same frequency in both sexes.
There was no breed predilection for hepatic neoplasms.
Clinical signs
Clinical signs at presentation (table 111) included anorexia, ascites, lethargy and vomiting. Ascites, diarrhea, jaundice and weight loss were more common signs in Vomiting was not common in dogs with bile duct carcinoma, but was common in dogs with the other three neoplasms. Myelopathy was seen in four dogs with hepatocellular carcinoma and in one with bile duct carcinoma. In four of these dogs (three with hepatocellular carcinoma and one with bile duct carcinoma), the myelopathy was caused by metastases; in the fifth, it was caused by protruding discs. Five dogs had seizures, but none had metastases in the brain. Seizures were attributed to hepatoencephalopathy .
Laboratory findings (table IV) All dogs with hepatic neoplasms had hematologic and biochemical abnormalities, especially those related to liver function. Serum alkaline phosphatase frequently was high, but elevated total serum bilirubin occurred less frequently. Jaundice was seen in 20% of the dogs (table 111) . Total serum bilirubin was highest in cases of carcinoid.
Aspartate amino transferase (SGOT) to alanine amino transferase (SGPT) ratio was less than one in cases of hepatocellular carcinoma and bile duct carcinoma, and was more than one in cases of carcinoid and sarcoma. In the bile duct carcinoma group, the SGPT content was more than twice that of SGOT. In cases of hepatocellular carcinoma and carcinoid, a larger percentage of dogs had higher SGPT levels.
Lactic dehydrogenase and total serum protein values were affected less often than SGOT and SGPT values. Lactic dehydrogenase was increased in up to 50% of the dogs, with the highest percent in dogs with carcinoid. Total serum protein was within normal limits in dogs of all groups except the hepatocellular group, in which 26% showed higher values. Glucose values were available for 12 dogs; two dogs, one with hepatocellular carcinoma and the other with leiomyosarcoma, were hypoglycemic. Both dogs were considered to have paraneoplastic syndromes.
A low erythrocyte count was found in 50% to 57% of the sarcoma, hepatocellular carcinoma and carcinoid cases for which data were available. In only one of the five dogs with bile duct carcinoma was there a reduced erythrocyte count. The range of the erythrocyte counts was widest in cases of hepatocellular carcinoma.
Leukocytosis with neutrophilia was found in 66% to 90% of dogs with hepatic neoplasms; the number of cells ranged from 4.3 to 61.0 x 103/pl. Leukocytosis was most common in the carcinoid group, with a higher average cell count (22.5 x lo3/ pl) than that of the hepatocellular carcinoma and bile duct carcinoma groups (19.0 x lo3/$). The highest average was seen in the dogs with sarcoma, although the percent of sarcoma cases with leukocytosis was similar to that of bile duct carcinoma cases. Leukocytosis was present in 66% of the dogs with hepatocellular carcinoma.
Gross findings
Grossly, the hepatic neoplasms were nodular, diffuse or massive (table V) . The nodular tumors were characterized by discrete nodules of various sizes in several lobes of the liver. In the diffuse type, the entire liver or part of it was permeated with neoplastic cells; in the massive type, a large mass was in one of the lobes, with or without secondary involvement of other lobes.
Fifty-four percent of the dogs with hepatocellular carcinoma had massive neoplasms; of these, 66% had the largest mass in the left lateral lobe. Forty-nine percent of the bile duct carcinomas were massive lesions, 56% of these in the left lateral lobe. The sarcoma group showed similar findings. In all groups except the carcinoid, the nodular type was more common than the diffuse. Most of the carcinoids (67%) were diffuse and usually involved more than one lobe.
Metastasis (table VI)
Metastases occurred in 61% of dogs with hepatocellular carcinoma, 86% with sarcoma, 88% with bile duct carcinoma and 93% with carcinoid. Peritoneal carcino-matosis was most common with the carcinoids and bile duct carcinomas. Lymph nodes were the most common sites for all epithelial tumors of the liver: 93% for carcinoid and 39% for hepatocellular carcinoma. The rate of metastasis to the lymph nodes for bile duct carcinoma was 67%. Fifty-seven percent of the sarcomas had metastases, most often to the spleen. The lungs were the next most common site for all neoplasms; frequency ranged from 13% for carcinoid to 54% for bile duct carcinoma. Other sites of metastasis were adrenal glands, kidneys, pancreas, gastrointestinal tract, spinal column and pituitary gland.
Cirrhosis and hepatic neoplasms
There were six cases of cirrhosis, four associated with hepatocellular carcinoma and two with bile duct carcinoma.
Additional neoplasms
Eleven dogs with hepatocellular carcinoma and two with carcinoid had additional neoplasms in other organs. Fourteen neoplasms of 11 different types, nine of them of endocrine, affected dogs with hepatocellular carcinoma (table VII) . Two dogs with carcinoid each had one additional neoplasm: one, a sebaceous gland adenoma and the other, a colonic leiomyoma. No additional neoplasms were seen in the other groups of hepatic neoplasms.
Discussion
The frequency of primary hepatic neoplasms in man varies in different studies from 0.2% to 0.46% of all autopsies. The incidence of hepatic carcinomas is 0.05% to 0.13%; 5% to 30% of these are hepatocellular carcinoma [l, 2,7, 13,251. Carcinoids and sarcomas are rare, and leiomyosarcomas are more common than fibrosarcomas [lo, 191. It is difficult to establish the frequency in the dog because of the lack of published reports. In a recent study [33] , primary hepatic tumors were found in 0.63% of all necropsies.
Primary hepatic neoplasms were found in 0.9% of our 12,245 canine necropsies. Hepatocellular carcinoma was the most common neoplasm; bile duct carcinoma followed. These findings agree with results reported previously [6, 15, 16, 23, 31] . Hepatocellular carcinoma also is more common than bile duct carcinoma and other hepatic neoplasms in the cat, sheep and pig [3, 21, 26, 36] . The frequency of hepatocellular carcinoma and bile duct carcinoma in cattle is variable [3] . In our study, 15 neoplasms were carcinoid and represented 14% of the hepatic neoplasms and 16% of the epithelial neoplasms. There have been no reports of hepatic carcinoid in the dog; the high frequency reported here can be attributed to the large number of cases examined, and to knowledge of the histologic features of these neoplasms.
Most dogs with hepatocellular carcinoma, bile duct carcinoma and sarcoma were over 10 years old. Most dogs with carcinoid were under 10 years old. This agrees with the equivalent age in man. As in dogs, hepatocellular carcinoma and sarcoma in man are more common in males; there is no sex predisposition for carcinoid in humans or dogs. There is no sex predisposition for bile duct carcinoma in man in most studies, but in our dogs there was a higher frequency in females [8,25,29, 32, 351. The most common presenting clinical signs in dogs with hepatic neoplasms were anorexia, ascites, lethargy and vomiting. Hepatomegaly was found in 42% of the cases. Abdominal pain, anorexia and malaise are the most common symptoms in man [2, 7, 13, 24, 25] . Jaundice, which is seen in one third of human patients with hepatocellular carcinoma and bile duct carcinoma [2, 12, 24, 251 , was not a consistent feature in the dogs of this series. The remaining clinical signs in the dog also are seen in man [2, 13, 24, 25] . Ascites, jaundice, diarrhea and weight loss were more frequent in dogs with carcinoid than in dogs with other types of neoplasms, probably because carcinoids involve the liver diffusely, extend most frequently to the peritoneal cavity with carcinomatosis, and are associated with production of serotonin, which can cause diarrhea [32, 35] .
Moderate anemia and leukocytosis are common in humans with hepatocellular carcinoma and bile duct carcinoma [2, 13, 241 . Leukocytosis is common in dogs with hepatic neoplasms, more so in dogs with bile duct carcinoma than with hepatocellular carcinoma [2, 13, 241 . In this series, anemia was seen most often in the carcinoid group and least often in the bile duct carcinoma group.
Serum alkaline phosphatase is one of the important tests for hepatic neoplasms in man; often it does not correlate with bilirubin values [2, 13, 24, 25] . In our dogs, increased serum alkaline phosphatase activity was a feature of all tumor types. The total serum bilirubin rarely correlated with increased levels of serum alkaline phosphatase.
Both SGOT and SGPT levels usually are increased with hepatocellular carcinoma and bile duct carcinoma in man and continue to increase with progression of the disease. The SGOT to SGPT ratio usually is greater than one in hepatocellular carcinoma but less than one in bile duct carcinoma [2, 13, 24, 301 . In this series, the SGPT values were greater than the SGOT values in both the hepatocellular carcinoma and bile duct carcinoma groups. The SGOT to SGPT ratio was more than one in the carcinoid and sarcoma groups. Serum lactic dehydrogenase was increased in a few cases of each type of neoplasm; this occasional or random increase in lactic dehydrogenase occurs in cases of human hepatocellular carcinoma and bile duct carcinoma [2, 13, 24, 25] . Serum total protein was normal in all groups except the hepatocellular carcinoma, where 26% showed a higher value with no change in the albumin to globulin ratio. Total protein usually remains within normal limits in man [2, 13, 24, 25] .
Hypoglycemia, hypercalcemia, thrombocytosis and polycythemia have been found in cases of hepatocellular carcinoma in man [2, 5, 13, 17, 201 . Hypoglycemia also is found in association with hepatic sarcomas, especially those of fibrous tissue origin in man [25] . In this study, one dog with hepatocellular carcinoma and another with leiomyosarcoma were hypoglycemic with no other apparent cause. Hypoglycemia has been seen in association with hepatocellular carcinoma [33, 341. The hepatic neoplasms in this study were described as nodular, diffuse or massive. Hepatocellular carcinomas most often had a large mass in one of the lobes, usually the left lateral lobe. In man the right lobe is affected more frequently than the left [7, 25, 261 . Massive lesions in man are more common in noncirrhotic liver [25] . Up to 88% of humans with hepatocellular carcinoma and 30% with bile duct carcinoma have cirrhosis [2, 7, 11, 24, 25] . Only four dogs with hepatocellular carcinoma had cirrhosis. The infrequency of cirrhosis in the dog may correlate with the frequency of massive lesions. Cirrhosis is thought to predispose to hepatocellular carcinoma in man, but the lack of correlation between cirrhosis and hepatocellular carcinoma in the dog suggests a different pathogenesis [2,7, 10,24, 251. Canine hepatic neoplasms had a high metastatic rate, ranging from 61% for the hepatocellular carcinomas to 93% for the carcinoids. Lymph nodes and lungs were the most common sites for all groups except the sarcoma, which most frequently metastasized to the spleen. Different studies report various frequencies of metastasis for hepatocellular carcinoma and bile duct carcinoma in man, but lymph nodes and lungs are the common sites [2, 13, 241 . The high rate of carcinomatosis in bile duct carcinoma and carcinoid may be due to the multicentricity and highly infiltrative nature of these neoplasms.
There were additional neoplasms in 11 dogs with hepatocellular carcinoma and two with carcinoid. The greater number of testicular neoplasms in this series may be explained by the predominance of older male dogs in the group. As in the dogs of this study, no significant association of multiple tumors with hepatocellular carcinoma and bile duct carcinoma has been noted in man [25] .
